#23andme — Public Fediverse posts

#23andMe Sale Shows Your #Genetic Data Is Worth $17
23andMe sold genetic data of 15M people for $256M to a #pharmaceutical #Regeneron. 23andMe does not perform full genome sequences. It instead does #DNA #genotyping, which look at parts of #genome that vary from person to person.
Sale to Regeneron means #gene data collected by 23andMe will be used for development of new #drugs, which felt like the most likely and perhaps best-case scenario for the company’s bankruptcy.
https://www.404media.co/23andme-sale-shows-your-genetic-data-is-worth-17/

23andMe and its customers’ genetic data bought by a pharmaceutical org https://www.malwarebytes.com/blog/news/2025/05/23andme-and-its-customers-genetic-data-bought-by-a-pharmaceutical-org #geneticdata #Regeneron #Privacy #23andMe #News

After Bankruptcy, 23andMe Finds a Buyer in Regeneron—But What Happens to Your Data? https://thecyberexpress.com/regeneron-acquire-23andme/ #RegeneronPharmaceuticals #Regeneronacquire23andMe #Mergers&Aquisitions #TheCyberExpressNews #23andmeacquisition #TheCyberExpress #FirewallDaily #BusinessNews #CyberNews #Regeneron #23andme

🧬 Breaking: Regeneron acquires 23andMe's assets for $256M, including genome and research services—but not Lemonaid Health. Deal awaits court approval amid privacy safeguards.

#23andMe #Regeneron #Biotech

#Biotech company #Regeneron to buy bankrupt #23andMe for $256M

Regeneron assured 23andMe's 15 million customers that their data—including #genetic and health information, #genealogy , and other sensitive personal information—would be safe and in good hands. Regeneron aims to use the large trove of genetic data to further its own work using genetics to develop medical advances—something 23andMe tried and failed to do.
#privacy #tos

https://arstechnica.com/science/2025/05/biotech-company-regeneron-to-buy-bankrupt-23andme-for-256m/

#23andMe Sale Shows Your #Genetic Data Is Worth $17

#Regeneron is a drug company that “intends to acquire 23andMe’s Personal #Genome Service (PGS), Total Health and Research Services business lines, together with its #Biobank and associated assets, for $256 million and for 23andMe to continue all consumer genome services uninterrupted,”
#privacy #dna #genetics

https://www.404media.co/23andme-sale-shows-your-genetic-data-is-worth-17/

🚀 Brace yourselves, folks! #23andMe just hit the "sell" button faster than you can say "privacy concerns," offloading their gene-testing biz to the DNA wizards at #Regeneron. 🤖 Meanwhile, #Bloomberg is busy breaking news and breaking our patience with their endless #CAPTCHA tests. 🧬
https://www.bloomberg.com/news/articles/2025-05-19/23andme-sells-gene-testing-business-to-dna-drug-maker-regeneron #geneTesting #privacyConcerns #HackerNews #ngated

23andMe Sells Gene-Testing Business to DNA Drug Maker Regeneron

https://www.bloomberg.com/news/articles/2025-05-19/23andme-sells-gene-testing-business-to-dna-drug-maker-regeneron

#HackerNews #23andMe #Regeneron #GeneTesting #DNAHealth #Biotech

Heads up. Get your data out of 23andMe right now -- or try.

(Anyone who put it in there in the first place was a fool, I have to say...)

Let's see if the U.S. Government buys it...

https://www.washingtonpost.com/technology/2025/03/24/23andme-dna-privacy-delete/

#DNA #genetics #GINA #genes #hereditary #familytree #bankrupt #bankruptcy #privacy #informationprivacy #compromised #dataleak #23andMe #data #fail #news #healthcare

#23andMe, the personal genomics company, went public in early 2021 via a merger with a blank check company that valued it at $3.5 billion.

Then its fortunes began to sink.

Fading interest in #DNA kits
– 23andMe’s main product
–  was one driver.

So was news last year that #hackers stole ancestry data on 6.9 million of its users.

CEO and co-founder #Anne #Wojcicki now reportedly wants to take the 18-year-old company private.

After her own proposal to buy it was rebuffed by its board in July,
she was given time to wangle another deal.

But its independent directors announced Tuesday evening they’ve lost faith that another proposal is coming,
adding that because of Wojcicki’s
“concentrated voting power,”
they’re done,
effective immediately.

The company’s market cap closed the day at $173 million.

Losing its glittering board
– which included Sequoia Capital’s #Roelof #Botha and YouTube CEO #Neal #Mohan, among five others
– will likely drive its shares down further.

One question is whether a shareholder lawsuit might follow.

https://techcrunch.com/2024/09/17/23andme-sees-independent-board-directors-quit-en-masse/